DexCom (DXCM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on DexCom (DXCM) is Neutral.

The composite score behind that read is +0.00, weighing +0.13 of bullish evidence against -0.27 bearish.

DexCom last closed at $84.11, -0.36% on the session.

Against the IVW growth benchmark the position is -1.16% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

13 graded predictions for DXCM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks DexCom in the 25th percentile on valuation and the 90th percentile on return on equity, where 100 is best.

DexCom is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $31.85B.

StockMap tracks DexCom as the 11th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite DexCom ranks 47th of 140 in the group, against a group median of -0.03.